MoneyWorks4Me

Norris Medicines - Quaterly Results

25 May 2023 Evaluate
The sales for the March 2023 quarter moved up 44.58% to Rs. 12.13 millions as compared to Rs. 8.39 millions during the corresponding quarter last year.The Net Loss for the quarter ended March 2023 is Rs. -5.43 millions as compared to Net Loss of Rs. -22.33 millions of corresponding quarter ended March 2022 Operating profit Margin for the quarter ended March 2023 improved to 5.58% as compared to -4.15% of corresponding quarter ended March 2022


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 12.13 8.39 44.58 83.58 94.38 -11.44 83.58 94.38 -11.44
Other Income 0.12 -0.04 -400.00 0.14 0.26 -46.15 0.14 0.26 -46.15
PBIDT 5.58 -4.15 -234.46 9.38 -0.46 -2139.13 9.38 -0.46 -2139.13
Interest 3.69 0.82 350.00 15.00 14.82 1.21 15.00 14.82 1.21
PBDT 1.89 -4.97 -138.03 -5.62 -15.28 -63.22 -5.62 -15.28 -63.22
Depreciation 1.76 6.57 -73.21 6.30 6.57 -4.11 6.30 6.57 -4.11
PBT 0.13 -11.54 -101.13 -11.92 -21.85 -45.45 -11.92 -21.85 -45.45
TAX 5.56 10.79 -48.47 5.56 10.79 -48.47 5.56 10.79 -48.47
Deferred Tax 5.56 10.79 -48.47 5.56 10.79 -48.47 5.56 10.79 -48.47
PAT -5.43 -22.33 -75.68 -17.48 -32.64 -46.45 -17.48 -32.64 -46.45
Equity 99.26 99.26 0.00 99.26 99.26 0.00 99.26 99.26 0.00
PBIDTM(%) 46.00 -49.46 -193.00 11.22 -0.49 -2402.59 11.22 -0.49 -2402.59
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..